Status:
ACTIVE_NOT_RECRUITING
Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer
Lead Sponsor:
Anhui Provincial Hospital
Conditions:
Progression-Free Survival
Overall Survival
Eligibility:
FEMALE
18+ years
Brief Summary
Ovarian cancer is one of the three major malignant tumors in gynecology, causing more than 200,000 deaths globally each year, with the highest mortality rate. However, due to its insidious onset and l...
Detailed Description
This is a non-interventional retrospective study to collect clinical data from patients with advanced epithelial ovarian cancer who underwent bowel surgery in the Department of Obstetrics and Gynecolo...
Eligibility Criteria
Inclusion
- Patients with advanced epithelial ovarian cancer who underwent bowel surgery (PDS, IDS, and SCS);
- FIGO (2014) staging of stage III to IV;
- Diagnosis was made between January 2017 and December 2023; ④Complete relevant clinical data.
Exclusion
- Combination of malignant tumors in other parts of the body not in remission or under treatment; ②Having an infectious disease in the infectious or active stage;
- Unknown status of visits to other hospitals and loss of visits; ④Not considered by the investigator to be suitable for enrollment or incomplete baseline information.
Key Trial Info
Start Date :
June 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06527001
Start Date
June 16 2024
End Date
December 31 2026
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anhui Provincal Hospital
Hefei, Anhui, China, 230000